3rd Quarter - Report — EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC (2022)

Firm

EMERGENT BIOSOLUTIONS INC.

Client

EMERGENT BIOSOLUTIONS INC

Income

—

Expenses

$520,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines H.R.3263 Outreach - DHS Medical Countermeasures Act

Lobbyist	Covered position, as disclosed
CHRIS FRECH	—
KATHERINE GETTY	—
JILL HAMAKER	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 5224 (117th), H.R. 2379 (117th), H.R. 4341 (117th), H.R. 2366 (117th), H.R. 6833 (117th), H.R. 3263 (117th), S. 3799 (117th), S. 987 (117th), H.R. 7666 (117th), H.R. 7681 (117th), S. 1457 (117th)

Disaster Planning/Emergencies DIS

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

Lobbyist	Covered position, as disclosed
CHRIS FRECH	—
KATHERINE GETTY	—
JILL HAMAKER	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 7666 (117th), S. 1457 (117th), S. 987 (117th), S. 3799 (117th), H.R. 6833 (117th), H.R. 5224 (117th), H.R. 3263 (117th), H.R. 4341 (117th), H.R. 7681 (117th), H.R. 2379 (117th), H.R. 2366 (117th)

Budget/Appropriations BUD

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

Lobbyist	Covered position, as disclosed
CHRIS FRECH	—
KATHERINE GETTY	—
JILL HAMAKER	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7666 (117th), S. 3799 (117th), H.R. 2379 (117th), H.R. 3263 (117th), H.R. 4341 (117th), H.R. 2366 (117th), H.R. 6833 (117th), S. 1457 (117th), H.R. 7681 (117th), H.R. 5224 (117th), S. 987 (117th)

Health Issues HCR

NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act

Lobbyist	Covered position, as disclosed
CHRIS FRECH	—
KATHERINE GETTY	—
JILL HAMAKER	—

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1457 (117th), H.R. 6833 (117th), H.R. 3263 (117th), S. 987 (117th), H.R. 2366 (117th), H.R. 7666 (117th), H.R. 2379 (117th), H.R. 5224 (117th), H.R. 4341 (117th), S. 3799 (117th), H.R. 7681 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.